VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 75 filers reported holding VOYAGER THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 0.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,508 | -32.3% | 1,743 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $19,957 | -79.3% | 1,743 | -80.7% | 0.00% | -50.0% |
| Q3 2020 | $96,542 | -15.5% | 9,048 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $114,186 | +37.9% | 9,048 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $82,789 | -34.4% | 9,048 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $126,220 | -18.9% | 9,048 | 0.0% | 0.00% | -33.3% |
| Q3 2019 | $155,716 | -36.8% | 9,048 | 0.0% | 0.00% | -25.0% |
| Q2 2019 | $246,287 | +42.2% | 9,048 | 0.0% | 0.00% | +33.3% |
| Q1 2019 | $173,179 | +103.6% | 9,048 | 0.0% | 0.00% | +50.0% |
| Q4 2018 | $85,051 | -50.3% | 9,048 | 0.0% | 0.00% | -33.3% |
| Q3 2018 | $171,188 | -99.9% | 9,048 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $176,798,000 | +59.7% | 9,048 | +53.6% | 0.00% | +50.0% |
| Q1 2018 | $110,692,000 | +112851.0% | 5,891 | 0.0% | 0.00% | +100.0% |
| Q4 2017 | $98,000 | -57.0% | 5,891 | -46.8% | 0.00% | 0.0% |
| Q3 2017 | $228,000 | – | 11,083 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 6,391,176 | $109,992,000 | 62.32% |
| Foresite Capital Management IV, LLC | 830,565 | $14,294,000 | 4.62% |
| Casdin Capital, LLC | 1,128,075 | $19,414,171,000 | 2.01% |
| ARMISTICE CAPITAL, LLC | 1,096,000 | $18,862,000 | 1.25% |
| Bellevue Group AG | 2,704,683 | $46,548,000 | 0.87% |
| PFM Health Sciences, LP | 1,231,954 | $21,202,000 | 0.63% |
| Boxer Capital, LLC | 500,000 | $8,605,000 | 0.62% |
| Aevitas Wealth Management, Inc. | 23,150 | $398,000 | 0.40% |
| 361 CAPITAL LLC | 120,143 | $2,068,000 | 0.38% |
| Birchview Capital, LP | 30,000 | $516,000 | 0.34% |